reports
Transactions in Connection with Share Buy-back Program
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; May 21, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from May 13, 2024 to May 17, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)Accumulated through last announcement 689,655 1,393,466,215.08May 13, 2024X...
Storaktionærmeddelelse – Direktør Svend Hornsylds Legat
Storaktionærmeddelelse – Direktør Svend Hornsylds Legat I henhold til § 30 i lov om kapitalmarkeder oplyses det hermed, at Direktør Svend Hornsylds Legat i henhold til § 38, stk. 1, i lov om kapitalmarkeder, har meddelt Aktieselskabet Schouw & Co., at Direktør Svend Hornsylds Legat den 17. maj 2024, som følge af den i Aktieselskabet Schouw & Co. gennemførte kapitalnedsættelse, har øget sin beholdning af aktier i selskabet til 15,12% af den samlede aktiekapital. Besiddelsen overstiger dermed 15%, jf. § 38 i lov om kapitalmarkeder. Aktieselskabet Schouw & Co. Jørgen Dencker...
Major shareholder announcement – Direktør Svend Hornsylds Legat
Major shareholder announcement – Direktør Svend Hornsylds Legat Pursuant to section 30 of the Danish Capital Markets Act, it is hereby announced that Direktør Svend Hornsylds Legat has notified Aktieselskabet Schouw & Co. pursuant to section 38(1) of the Danish Capital Markets Act that Direktør Svend Hornsylds Legat on 17 May 2024, as a result of the capital reduction carried out in Aktieselskabet Schouw & Co., increased its holding of treasury shares in the company to 15.12% of the total share capital. The holding thus exceeds 15%, cf. section 38 of the Danish Capital Markets Act. ...
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy ...
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics This regulatory clearance enables clinical development of SAB-142 in patients with type 1 diabetes in the US MIAMI, May 21, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), today announced that the U.S. Food and Drug Administration (FDA) has provided clearance for the Company’s investigational new drug (IND) application to proceed for its phase 1 clinical trial for type 1 diabetes (T1D) therapy SAB-142. SAB is a clinical-stage biopharmaceutical compan...
STLLR Gold Announces Exploration Drilling Results at the Tower Gold Pr...
Toronto, Ontario--(Newsfile Corp. - May 21, 2024) - STLLR Gold Inc. (TSX: STLR) (OTCQX: STLRF) (FSE: O9D) ("STLLR" or the "Company") announces the assay results from the exploration drilling of prospective targets near the 55 Zone and Westaway Deposits at the Golden Highway Area (western end) of the Tower Gold Project in Timmins, Ontario, Canada. Exploration drilling at the Colomac Gold Project in the Northwest Territories, Canada, has also commenced. Table 1: 2024 Exploration Drilling Highlights - 55 Zone West and Westaway South Limb Targets(See Figures 1-4):TargetsHole IDAssay Result55 Zone ...
Moody's Ratings assigns a Ba2 rating to Coty's new senior secured note...
Moody's Ratings (Moody's) assigned a Ba2 rating to Coty, Inc.'s ("Coty") new senior secured notes. All other ratings including the company's Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating (PDR), Ba2 senior secured revolver and notes ratings, B1 senior unsecured note ratings ...
Stellantis to Participate in Bernstein 40th Annual Strategic Decision...
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference AMSTERDAM, May 21, 2024 – Carlos Tavares, Stellantis Chief Executive Officer, will participate in a fireside chat on Wednesday, May 29, 2024, at 9:00 a.m. EDT / 3:00 p.m. CEST at the Bernstein 40th Annual Strategic Decisions Conference. To watch the live session, visit the following webcast link: Details for watching the fireside chat are also available under the section of the Stellantis corporate website. For those unab...
Munchener Ruckversicherungs-Gesellschaft AG: 1 director
A director at Munchener Ruckversicherungs-Gesellschaft AG bought 110 shares at 457.800EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Jinyoung Co Ltd: 1 director
A director at Jinyoung Co Ltd sold 43,103 shares at 3,404.346KRW and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Clearside Biomedical Announces Publication of Consensus Guidelines for...
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® - Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience Support SCS Injection as a Safe and Effective Method for Delivering Retinal and Choroidal Therapeutics - ALPHARETTA, Ga., May 21, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical compan...
Xtract One Announces Fiscal 2024 Third Quarter Conference Call
Xtract One Announces Fiscal 2024 Third Quarter Conference Call TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that it will release fiscal 2024 third quarter results after the close of trading on June 6, 2024. Peter Evans, Xtract One CEO and Director, and Karen Hersh, CFO and Corporate Secretary, will host a webcast and conference call at 10:00 a.m. Ea...
Copenhagen Capital A/S – Periodemeddelelse for 1. kvartal 2024
Copenhagen Capital A/S – Periodemeddelelse for 1. kvartal 2024 Copenhagen Capital A/S afgiver periodemeddelelse for 1. kvartal 2024. Selskabet offentliggør ikke finansiel information som en del af periodemeddelelser. Driften af ejendommene forløber som forventet. Selskabet har i perioden haft fortsat fokus på drift af porteføljen og tomgangen er lav. Selskabet er arbejder med projekteringen og indhentning af priser for tagboligprojektet på Ole Suhrs Gade 13-15, København K. Selskabet har i perioden tilbagekøbt de resterende 8.684.791 stk. 8% Præferenceaktier 2024. Aktierne ble...
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of...
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject to market conditions and other factors, $500,000,000 aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). BlackLine also intends to grant the initial purchaser of the notes a 13-day option to purchase...
Tejas Networks Ltd: 5 directors
Seven Directors at Tejas Networks Ltd sold 17,657 shares at between 1,145.102INR and 1,224.455INR. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free ...
Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free June 1 – August 31 New study finds that ninety per cent of Canadian teens believe physical activity can positively impact their lives and boost mental health1 TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- , one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, announces the return of its High School Summer Pass™ program, inviting high school teens ages 14 – 192 to work out for free at any of its 2,500+ Planet Fitness locations across the U.S. and...
American Shared Hospital Services Announces Annual Shareholder Meeting...
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024 Meeting Will be Held at The Hilton Hotel, San Francisco, CA SAN FRANCISCO, May 21, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The Annual Meeting will be an in-person meeting. For tho...
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal P...
PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal Proceedings MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. () (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce that its wholly-owned subsidiary Pyro Green-Gas Inc. and certain related persons (collectively, the “PGG Parties”) have settled all o...
BioXcel Therapeutics Announces Oral and Poster Presentations at the 20...
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer of Neuroscience, will deliver oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. The meeting will ...
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Gras...
BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Grassy Mountain Gold and Silver Mine WINNEMUCCA, Nev., May 21, 2024 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is pleased to announce its proposed Grassy Mountain gold mine will have the benefit of a joint reclamation bond between the Oregon Department of Geology and Mineral Industries (the “DOGAMI”) and the Bureau of Land Management (“BLM”). The two agencies have executed a Memorandum of Understanding (“MOU”) which ensures that Paramount will not be required to post ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.